Your browser doesn't support javascript.
loading
Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis.
Inaki, Koichiro; Shibutani, Tomoko; Maeda, Naoyuki; Eppenberger-Castori, Serenella; Nicolet, Stefan; Kaneda, Yuki; Koyama, Kumiko; Qiu, Yang; Wakita, Kenichi; Murakami, Masato.
Afiliación
  • Inaki K; Translational Science Department I, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Shibutani T; Translational Research Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan.
  • Maeda N; Translational Science Department I, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Eppenberger-Castori S; Translational Research Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan.
  • Nicolet S; Translational Science Department I, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Kaneda Y; Pathology, Universitätsspital Basel, Basel, Switzerland.
  • Koyama K; Pathology, Universitätsspital Basel, Basel, Switzerland.
  • Qiu Y; Translational Science Department I, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Wakita K; Translational Science Department I, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Murakami M; Global Oncology R&D, Daiichi Sankyo, Inc., Basking Ridge, NJ, United States of America.
PLoS One ; 17(9): e0274140, 2022.
Article en En | MEDLINE | ID: mdl-36137139

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoconjugados / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoconjugados / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article